Phase II/III trial of Imprime PGG in patients with Gastric cancer

Trial Profile

Phase II/III trial of Imprime PGG in patients with Gastric cancer

Planning
Phase of Trial: Phase II/III

Latest Information Update: 18 Apr 2016

At a glance

  • Drugs PGG-glucan (Primary)
  • Indications Gastric cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Biothera
  • Most Recent Events

    • 18 Apr 2016 According to a Biothera Pharmaceuticals media release, this trial is scheduled to begin in 2016.
    • 01 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top